DRUG · Mapped RxNorm record
apixaban
Normalized identity: apixabanView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
NCT02942407
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
warfarin
Normalized identity: warfarinView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedTrial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
apixabanDRUG · verified · RxNorm: apixaban
warfarinDRUG · verified · RxNorm: warfarin
Sponsors & collaborators
Christopher Granger, MDlead sponsor
Bristol-Myers Squibbcollaborator
Mapped research locations
MiamiFlorida, United States3Long BeachCalifornia, United States2HoustonTexas, United States1BostonMassachusetts, United States1ChicagoIllinois, United States1BaltimoreMaryland, United States1St LouisMissouri, United States1SeattleWashington, United States1ColumbusOhio, United States1DurhamNorth Carolina, United States1Washington D.C.District of Columbia, United States1Salt Lake CityUtah, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02942407 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.